Results 141 to 150 of about 11,750 (219)

Efficacy and Safety Evaluation of a Ready-to-Use Bivalent Porcine Circovirus Type 2 and <i>Mycoplasma hyopneumoniae</i> Vaccine in China. [PDF]

Vaccines (Basel)
Yan H, Mo Y, Luo W, Xie X, Li Z, Tang S, Liu X, Cao Q, Lin H, Gao D, Del Pozo Sacristan R, Wang X.   +11 more
europepmc   +1 more source

Annexin A2 facilitates porcine circovirus type 2 infection by mediating viral attachment to host cells and interacting with the capsid protein. [PDF]

Vet Res
Jiang Y, Lei X, Liu W, Cao S, He Q, Xie X, Zhan Y, Tan L, Mai J, Yang L, Wang A, Yang Y, Wang N.   +12 more
europepmc   +1 more source

Prevalence and genetic characterization of porcine circovirus type 2, 3 and 4 in the upper Northern region of Thailand. [PDF]

Vet Res Commun
Anukool W, Yamsakul P.
europepmc   +1 more source

Functional and evolutionary analysis of host Synaptogyrin-2 in porcine circovirus type 2 susceptibility. [PDF]

PLoS Genet, 2023
Walker LR, Vu HL, Montooth KL, Ciobanu DC.   +3 more
europepmc   +1 more source

Epidemiological Survey of Porcine Circovirus Type 2 (PCV2) in Large-Scale Pig Farms in Hubei Province and Comprehensive Evaluation of Commercial Vaccine Efficacy. [PDF]

Vaccines (Basel)
Liao W, Xi Z, Fang R, Shen B, Zhao J.
europepmc   +1 more source

Isolation and pathogenicity of porcine circovirus type 2 in mice from Guangxi province, China. [PDF]

Virol J, 2023
Jiao Q, Yang L, Liu X, Wen Y, Tian L, Qian P, Chen H, Li X.   +7 more
europepmc   +1 more source

Molecular Epidemic Characteristics and Genetic Evolution of Porcine Circovirus Type 2 in Henan, China. [PDF]

Vet Sci
Peng Z, Lv H, Zhang H, Zhao L, Li H, He Y, Zhao K, Qiao H, Song Y, Bian C.   +9 more
europepmc   +1 more source

The Evaluation of a Porcine Circovirus Type 2 (PCV2) Intradermal Vaccine Against a PCV2 Field Strain. [PDF]

Vaccines (Basel)
Hsieh CK, Chien CY, Liu CW, Chang SW, Lin H, Ellerma L, Chiou MT, Lin CN.   +7 more
europepmc   +1 more source

Cellular immune signatures and differences of four porcine circovirus type 2 vaccines to heterologous PCV2d infection. [PDF]

NPJ Vaccines
Li S, Liu J, Meng L, Yin S, Wu H, Zou J, Yuan D, He H, Yin G, Jia X, Hao X, Shang S.   +11 more
europepmc   +1 more source

Metal-organic framework-based delivery systems as nanovaccine for enhancing immunity against porcine circovirus type 2. [PDF]

Mater Today Bio
Ding LG, Shi M, Yu ED, Xu YL, Zhang YY, Geng XL, Liu F, Li JD, Chen Z, Yu J, Wu JQ.   +10 more
europepmc   +1 more source